Predict your next investment

SiBreaX company logo
HEALTHCARE | Drug Development
sibreax.com

See what CB Insights has to offer

Founded Year

2017

Stage

Incubator/Accelerator | Alive

Total Raised

$10K

Last Raised

$10K | 2 yrs ago

About SiBreaX

SiBreaX develops stimulus-responsive silicate-based nano-/microparticles for targeted drug/compound delivery and degradable, injectable nanocomposite hydrogels for biomedical and topical applications.

SiBreaX Headquarter Location

Technoparkstrasse 1

Kilchberg, 8802,

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SiBreaX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SiBreaX is included in 2 Expert Collections, including Nanobiotechnology.

N

Nanobiotechnology

704 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

M

Medical Devices

7,496 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.